Pharmaceutical Benefit Managers, Brand-Name Drug Prices, and Patient Cost Sharing

The prices patients pay for brand-name medications are rising faster than many other medical care costs. Some observers claim that the business practices of pharmaceutical benefit managers are partly responsible. How the process works is complicated, and this article explains what is happening.

http://ift.tt/2nVL2hw